Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

For further information, see CMDT Part 24-30: Polyneuropathies & Mononeuritis Multiplex

Key Features

  • Axonal polyneuropathy may follow exposure to

    • Industrial agents or pesticides, such as acrylamide, organophosphorus compounds, hexacarbon solvents, methyl bromide, and carbon disulfide

    • Metals, such as arsenic, thallium, mercury, and lead

    • High doses of such certain medications, such as phenytoin, amiodarone, perhexiline, isoniazid, nitrofurantoin, vincristine, and pyridoxine

  • Bulbar and distal sensorimotor polyneuropathy may follow diphtheria

Clinical Findings

  • Diphtheritic neuropathy

    • Results from a neurotoxin released by the causative organism and is common in many areas

    • Palatal weakness may develop 2–4 weeks after infection of the throat

    • Infection of the skin may similarly be followed by focal weakness of neighboring muscles

    • Disturbances of visual accommodation may occur about 4–5 weeks after infection

    • Distal sensorimotor demyelinating polyneuropathy may occur after 1–3 months

Diagnosis

  • Detailed occupational, environmental, and medical histories and recognition of clusters of cases are important in suggesting the diagnosis

Treatment

  • Prevent further exposure to the causal agent

  • Isoniazid neuropathy is prevented by pyridoxine supplementation

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.